Platelets, coronary heart disease, and stress

Lena Brydon1, Kesson Magid, Andrew Steptoe

  • 1The Psychobiology Group, Department of Epidemiology and Public Health, University College London, London, UK. l.brydon@public-health.ucl.ac.uk

Insights

Psychological stress elevates platelet-leukocyte aggregates, a key factor in coronary heart disease development. This platelet activation may link stress to increased cardiac risk and trigger acute coronary syndromes.

Area of Science:

  • Cardiovascular Medicine
  • Psychoneuroimmunology
  • Hematology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality, linked to chronic stress and psychosocial factors.
  • Atherosclerosis, the underlying pathology of CHD, involves inflammatory processes and endothelial dysfunction.
  • Platelets are crucial in atherosclerosis by interacting with leukocytes, promoting their recruitment to the endothelium.

Purpose of the Study:

  • To investigate the role of platelet activation in linking psychosocial stress to coronary heart disease.
  • To explore how platelet-leukocyte interactions contribute to the inflammatory processes in atherosclerosis.
  • To examine the impact of acute psychological stress on platelet activation and its implications for cardiac patients.

Main Methods:

  • Analysis of circulating platelet-leukocyte aggregates in various populations.
  • Assessment of platelet activation in individuals experiencing different levels of psychological stress.
  • Comparison of stress-induced platelet activation in healthy individuals versus cardiac patients.

Main Results:

  • Elevated platelet-leukocyte aggregates are observed in cardiac patients and individuals with chronic stress.
  • Increased platelet activation is associated with depression, hostility, and work-related stress.
  • Acute psychological stress significantly increases circulating platelet-leukocyte aggregates, with a prolonged effect in cardiac patients.

Conclusions:

  • Platelet activation serves as a potential mechanism connecting psychosocial stress to heightened coronary risk.
  • Platelet-leukocyte interactions may contribute to the inflammatory nature of atherosclerosis.
  • Platelet activation could play a role in the emotional triggering of acute coronary syndromes in advanced coronary disease.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...